Phase 2 study of everolimus for relapsed or refractory classical Hodgkin lymphoma

BACKGROUND: The current standard of care for classical Hodgkin lymphoma (HL) is multiagent chemotherapy with or without radiation. In patients who relapse or fail to respond, additional high-dose chemotherapy with autologous hematopoietic stem cell transplantation (AHSCT) can improve progression-fre...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Exp Hematol Oncol
Huvudupphovsmän: Johnston, Patrick B., Pinter-Brown, Lauren C., Warsi, Ghulam, White, Kristen, Ramchandren, Radhakrishnan
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2018
Ämnen:
Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5948762/
https://ncbi.nlm.nih.gov/pubmed/29774169
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40164-018-0103-z
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk